Maximal Usage Trials for Topically Applied Active Ingredients Being Considered for Inclusion in an Over-The-Counter Monograph: Study Elements and Considerations
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
May 10, 2019
April 11, 2024
aba27acd-a192-453b-9d48-dde390d1e56f
Related Documents
Developing Targeted Therapies in Low-Frequency Molecular Subsets of a Disease
Guidance DocumentOctober 16, 2018Center for Drug Evaluation and Research
Considerations in Demonstrating Interchangeability With a Reference Product Guidance for Industry
Guidance DocumentMay 14, 2019Center for Drug Evaluation and Research
Considerations for the Inclusion of Adolescent Patients in Adult Oncology Clinical Trials
Guidance DocumentMarch 13, 2019Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.